中文名称:那格列奈
  • (-)-N-(反-4-异丙基环己基羰基)-D-苯丙氨酸; 那格列萘; N-(反-4-异丙基环己基羰基)-D 苯丙氨酸; N-(反式-4-异丙基环己基甲酰)-D-苯丙氨酸;
  • Nateglinide
  • N-(trans-4-Isopropylcylcohexylcarbonyl)-D-phenylalanine; 3-Phenyl-2-(4-propan-2-ylcyclohexyl)carbonylamino-propanoic acid; nateglinide intermediate; N-{[4-(propan-2-yl)cyclohexyl]carbonyl}phenylalanine; N-{[4-(propan-2-yl)cyclohexyl]carbonyl}-L-phenylalanine; N-{[(1S,3S)-3-(propan-2-yl)cyclohexyl]carbonyl}-D-phenylalanine; N-{[4-(1-methylethyl)cyclohexyl]carbonyl}-D-phenylalanine; N-{[trans-4-(propan-2-yl)cyclohexyl]carbonyl}-D-phenylalanine
  • 105816-04-4
  • C19H27NO3
  • 317.4226
  • InChI=1/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15-,16-,17-/m1/s1
  • 那格列奈 105816-04-4
  • 1.105g/cm3
  • 137-141℃
  • 527.578°C at 760 mmHg
  • 272.869°C
  • 0mmHg at 25°C
  • 熔点 137-141°C
  • 用于治疗糖尿病